98 related articles for article (PubMed ID: 15707492)
1. Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28).
Mavoungou D; Poaty-Mavoungou V; Akoume MY; Ongali B; Mavoungou E
Virol J; 2005 Feb; 2():9. PubMed ID: 15707492
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by immunor (IM28), a new analog of dehydroepiandrosterone.
Diallo K; Loemba H; Oliveira M; Mavoungou DD; Wainberg MA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):2019-24. PubMed ID: 11200288
[TBL] [Abstract][Full Text] [Related]
3. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
Broder CC; Dimitrov DS; Blumenthal R; Berger EA
Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
[TBL] [Abstract][Full Text] [Related]
4. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania.
Easterbrook MD; Levy MH; Gomez AM; Turco SJ; Epand RM; Rosenthal KL
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):496-505. PubMed ID: 8548328
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro.
Das AT; Land A; Braakman I; Klaver B; Berkhout B
Virology; 1999 Oct; 263(1):55-69. PubMed ID: 10544082
[TBL] [Abstract][Full Text] [Related]
9. A semiautomated fluorescence-based cell-to-cell fusion assay for gp120-gp41 and CD4 expressing cells.
Pine PS; Weaver JL; Oravecz T; Pall M; Ussery M; Aszalos A
Exp Cell Res; 1998 Apr; 240(1):49-57. PubMed ID: 9570920
[TBL] [Abstract][Full Text] [Related]
10. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.
Pontow SE; Heyden NV; Wei S; Ratner L
J Virol; 2004 Jul; 78(13):7138-47. PubMed ID: 15194790
[TBL] [Abstract][Full Text] [Related]
11. Discriminating in vitro cell fusion from cell aggregation by flow cytometry combined with fluorescence resonance energy transfer.
Huerta L; López-Balderas N; Larralde C; Lamoyi E
J Virol Methods; 2006 Dec; 138(1-2):17-23. PubMed ID: 16934339
[TBL] [Abstract][Full Text] [Related]
12. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis.
Guillerm C; Robert-Hebmann V; Hibner U; Hirn M; Devaux C
Virology; 1998 Sep; 248(2):254-63. PubMed ID: 9721234
[TBL] [Abstract][Full Text] [Related]
13. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
[TBL] [Abstract][Full Text] [Related]
14. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
15. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4.
Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M
J Clin Invest; 2006 Aug; 116(8):2161-72. PubMed ID: 16886061
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication by RNA interference of p53 expression.
Pauls E; Senserrich J; Clotet B; Esté JA
J Leukoc Biol; 2006 Sep; 80(3):659-67. PubMed ID: 16844765
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication.
Henderson E; Yang JY; Schwartz A
AIDS Res Hum Retroviruses; 1992 May; 8(5):625-31. PubMed ID: 1381206
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes.
Wang X; Douglas SD; Peng JS; Metzger DS; O'Brien CP; Zhang T; Ho WZ
J Leukoc Biol; 2006 Jun; 79(6):1166-72. PubMed ID: 16574767
[TBL] [Abstract][Full Text] [Related]
19. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.
Vlahakis SR; Bren GD; Algeciras-Schimnich A; Trushin SA; Schnepple DJ; Badley AD
Clin Pharmacol Ther; 2007 Sep; 82(3):294-9. PubMed ID: 17361127
[TBL] [Abstract][Full Text] [Related]
20. HIV-induced syncytia in peripheral blood cell cultures crawl by extending giant pseudopods.
Shutt DC; Stapleton JT; Kennedy RC; Soll DR
Cell Immunol; 1995 Dec; 166(2):261-74. PubMed ID: 7497528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
